CIM
BIO icon

CIM Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

CIM Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$417K Sell
1,497
-7
-0.5% -$2.02K 0.11% 147
2025
Q4 		$456K Hold
1,504
– – 0.12% 141
2025
Q3 		$422K Sell
1,504
-1,544
-51% -$420K 0.11% 141
2025
Q2 		$869K Buy
3,048
+1,521
+100% +$360K 0.17% 115
2025
Q1 		$372K Sell
1,527
-1
-0.1% -$301 0.08% 143
2024
Q4 		$502K Buy
1,528
+7
+0.5% +$2.38K 0.15% 115
2024
Q3 		$509K Sell
1,521
-28
-2% -$8.89K 0.15% 118
2024
Q2 		$423K Sell
1,549
-9
-0.6% -$2.62K 0.13% 139
2024
Q1 		$539K Hold
1,558
– – 0.16% 124
2023
Q4 		$503K Sell
1,558
-88
-5% -$27.6K 0.16% 128
2023
Q3 		$590K Sell
1,646
-38
-2% -$14.7K 0.22% 100
2023
Q2 		$638K Buy
1,684
+4
+0.2% +$1.63K 0.22% 98
2023
Q1 		$805K Buy
1,680
+1,115
+197% +$522K 0.3% 68
2022
Q4 		$238K Sell
565
-16
-3% -$6.46K 0.09% 199
2022
Q3 		$242K Hold
581
– – 0.11% 179
2022
Q2 		$288K Sell
581
-3
-0.5% -$1.56K 0.12% 167
2022
Q1 		$329K Buy
+584
New +$352K 0.11% 171

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CIM Investment Management's BIO Position: Q1 2026 in Review

CIM Investment Management reduced its Bio-Rad Laboratories Class A (BIO) stake by 0.47% in Q1 2026, selling an estimated $2.02K and leaving 1,497 shares worth $417K. The position accounts for 0.11% of the portfolio, ranked #147.

CIM Investment Management first reported a position in BIO in Q1 2022 and has held it in 17 quarters since. The position peaked at $869K in Q2 2025. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • CIM Investment Management held 1,497 shares of Bio-Rad Laboratories Class A worth $417K as of Q1 2026.
  • CIM Investment Management sold 7 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $2.02K.
  • Bio-Rad Laboratories Class A made up 0.11% of CIM Investment Management's portfolio in Q1 2026, its #147 holding.
  • CIM Investment Management first reported a position in Bio-Rad Laboratories Class A in Q1 2022 and has held it in 17 quarters since.
  • CIM Investment Management's Bio-Rad Laboratories Class A position peaked at $869K in Q2 2025.
  • 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.